Department of Surgery, Center for Transplantation Sciences, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States.
Department of Surgery, Division of Cardiac Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States.
Front Immunol. 2021 Sep 9;12:681504. doi: 10.3389/fimmu.2021.681504. eCollection 2021.
The recent dramatic advances in preventing "initial xenograft dysfunction" in pig-to-non-human primate heart transplantation achieved by minimizing ischemia suggests that ischemia reperfusion injury (IRI) plays an important role in cardiac xenotransplantation. Here we review the molecular, cellular, and immune mechanisms that characterize IRI and associated "primary graft dysfunction" in allotransplantation and consider how they correspond with "xeno-associated" injury mechanisms. Based on this analysis, we describe potential genetic modifications as well as novel technical strategies that may minimize IRI for heart and other organ xenografts and which could facilitate safe and effective clinical xenotransplantation.
最近,通过最小化缺血来预防猪到非人类灵长类动物心脏移植中的“初始异种移植物功能障碍”方面取得了显著进展,这表明缺血再灌注损伤(IRI)在心脏异种移植中起着重要作用。在这里,我们综述了分子、细胞和免疫机制,这些机制可用于描述同种异体移植中的 IRI 和相关的“原发性移植物功能障碍”,并考虑它们与“异种相关”损伤机制的对应关系。基于此分析,我们描述了潜在的基因修饰以及可能最小化心脏和其他器官异种移植物的 IRI 的新技术策略,这可能有助于安全有效地进行临床异种移植。